Area of Research: Targeted Therapy
2022 Grant Recipients
-
Pamela Rojas de Santiago, PhD,
University of Pennsylvania
Mentored Investigator GrantInvestigating the Therapeutic Potential of CRABP2 in HGSOC
2021 Grant Recipients
-
Anne M. van Harten, PhD,
Thomas Jefferson University
Mentored Investigator GrantTargeted MDM2 Degradation as a Novel Treatment for Ovarian Cancer
-
Wei Zhou, PhD,
The Wistar Institute
Mentored Investigator GrantTargeting the mevalonate pathway in ARID1A-mutated ovarian cancer
2020 Grant Recipients
-
Jianhuang Lin, PhD,
The Wistar Institute
Mentored Investigator GrantTargeting ER Stress Pathway in CARM1-Expressing Ovarian Cancer
-
Boris Winterhoff, MD,
University of Minnesota Twin Cities
Early Career Investigator GrantPrecision Medicine in Ovarian Cancer: Using Single Cell Analysis
2018 Grant Recipients
-
Goldie Lui, PhD,
Fred Hutchinson Cancer Research Center
Mentored Investigator GrantIdentifying Novel Targeted Therapies for MYC-driven Ovarian Cancer
-
David Sabatini, MD, PhD,
Whitehead Institute for Biomedical Research
Collaborative Research Development GrantA Personalized Approach to Identify and Target Ovarian Cancer Liabilities
2017 Grant Recipients
-
Ie-Ming Shih, MD, PhD,
Johns Hopkins University School of Medicine
Collaborative Research Development GrantDevelopment of Targeted Therapies for Recurrent Ovarian Cancer
2015 Grant Recipients
-
Sarah Walker, PhD,
Dana Farber Cancer Institute
Early Career Investigator GrantTargeting Transcription Factor Networks for Ovarian Cancer Therapy
-
Kris Wood, PhD,
Duke University
Early Career Investigator GrantDefining New Combination Therapies for High-grade Serous Ovarian Cancer